Abstract:Objective: Calcification plays a major role in the failure of bioprosthetic and other tissue heart valve substitutes. The objective of this study was to evaluate the anticalcification effect of decellularization and detoxification in glutaraldehyde (GA)/genipin- and solvent-fixed bovine pericardium using a rabbit intramuscular model which is effective for assessing calcification in bioprosthetic tissue. Methods: Bovine pericardial tissues were fixed with 0.5% GA/0.4% genipin in organic solvent (75% ethanol + 5% octanol, 75% ethanol + 5% octanediol, or 70% ethanol + 10% isopropanol) and post-treated with glycine, glutamic acid, or sodium bisulfite. Decellularization was performed with 0.25% sodium dodecylsulfate prior to fixation. The material characteristics of the treated tissues were assessed by thermal stability test, uniaxial mechanical test, and light microscopy. Stability of the treated tissue was measured by the resistance to enzymatic degradation using protease. The tissues were intramuscularly implanted into 4-week-old rabbits for 8 weeks, and the anti-α-Gal(Gal[alpha]1,3-Gal[beta]1,4GlcNAc-R) antibodies (immunoglobulin G) were measured at various time intervals after implantation. Explanted tissues were examined by light microscopy and calcium contents of the explanted tissues were measured. Results: Differently treated tissues resulted in no significant alterations in material characteristics and morphology. GA groups are superior to genipin groups in tissue cross-linking without difference according to addition of decellularization, organic solvent treatment, and detoxification by resistance toward pronase degradation. The titer of anti-α-Gal antibodies gradually increased after implantation in all study groups. The titer of anti-α-Gal antibodies increased less in genipin groups than in GA groups, and less with decellularization than without decellularization. The calcium contents of genipin groups (n = 75) were significantly lower than those of GA groups (n = 118) (28.55 ± 11.22 μg mg(-1) vs 37.16 ± 7.75 μg mg(-1), p < 0.001). Calcium contents decreased with decellularization, organic solvent treatment, and detoxification, irrespective of the type of organic solvent and amino acids. Inorganic phosphorus contents of genipin groups (n = 66) were significantly lower than those of GA groups (n = 103) (55.36 ± 26.98 μg mg(-1) vs 75.67 ± 23.44 μg mg(-1), p = 0.000). Conclusions: Genipin fixation is a novel alternative to conventional GA fixation in vitro material assessment and in vivo anticalcification effect. The addition of decellularization, organic solvent treatment, and detoxification prevented calcification of GA/genipin-fixed bovine pericardium in the rabbit intramuscular implantation model, irrespective of the type of organic solvent and amino acids.

Research on the Feature of 2, 3 - Butanediol Post - Treatment for Glutaraldehyde Tanned Bovine Pericardium

Glutaraldehyde and 2,3-butanediol treatment of bovine pericardium for aortic valve bioprosthesis in sheep: a preliminary study

Biological Properties of Autologous Pericardium Treated with Glutaraldehyde in Vitro

Immunogenicity of Glutaraldehyde Tanned Bovine Pericardium with Polydiol-post Treatment

Compound Tanning Biological Material with Cation Fat in Artificial Biovalve

The Preparation of Acellular Bovine Pericardium Bio-derived Material and the Study of It's Properties

Nonglutaraldehyde Fixation for off the Shelf Decellularized Bovine Pericardium in Anticalcification Cardiac Valve Applications

The Study of Dry Biological Valve Crosslinked with a Combination of Carbodiimide and Polyphenol

Prevention of Tissue Calcification on Bioprosthetic Heart Valve by Using Epoxy Compounds: a Study of Calcification Tests in Vitro and in Vivo.

[Effects of freeze-drying bovine pericardium using a combination of polyethylene glycol and trehalose]

Research on Anticoagulant Properties of Heparinized EDC-PEI Treated Acellular Bovine Pericardiums

Crosslinking of Bovine Pericardia Using Procyanidins

Comparison of Decellularizative Procedures of Bovine Pericardium Tissue-Engineering Heart Valve Scaffold

Anticalcification effects of decellularization, solvent, and detoxification treatment for genipin and glutaraldehyde fixation of bovine pericardium

Bioprosthetic Heart Valves’ Structural Integrity Improvement Through Exogenous Amino Donor Treatments

Improved biocompatibility of bioprosthetic heart valves by L-glutamic acid treatment

In vivo application of a glutaraldehyde-free, UVA/riboflavin cross-linked bovine pericardium confirms suitability for cardiovascular substitutes

[The Advantages of Bovine Jugular Vein Tanned with Hydrophilia Crosslinking Agent].

Cross-Linking Porcine Pericardium by 3,4-Dihydroxybenzaldehyde: A Novel Method to Improve the Biocompatibility of Bioprosthetic Valve

Curcumin-crosslinked acellular bovine pericardium for the application of calcification inhibition heart valves

Impact of Long-term Storage in 4% Formaldehyde on Immunophenotypic Markers in Glutaraldehyde-treated Bovine Pericardium